Greenyn Biotechnology Co (ROCO:6846) Total Tax Payable: NT$14.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6846 Greenyn Biotechnology Co Ltd ROCO:6846
68 GF Score
Price NT$57.60
GF Value NT$67.05
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Greenyn Biotechnology Co Total Tax Payable?

Greenyn Biotechnology Co ROCO:6846 +0.35% 68 Total Tax Payable is NT$14.6 Mil as of Jun. 2026. GuruFocus rates ROCO:6846 with a GF Score™ of 68/100 and a GF Value™ of NT$67.05 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Greenyn Biotechnology Co's Total Tax Payable for the quarter that ended in Jun. 2026 was NT$14.6 Mil.

Greenyn Biotechnology Co's quarterly Total Tax Payable increased from Dec. 2025 (NT$24.5 Mil) to Mar. 2026 (NT$32.7 Mil) but then declined from Mar. 2026 (NT$32.7 Mil) to Jun. 2026 (NT$14.6 Mil).

Greenyn Biotechnology Co's annual Total Tax Payable increased from Dec. 2023 (NT$17.5 Mil) to Dec. 2024 (NT$22.5 Mil) and increased from Dec. 2024 (NT$22.5 Mil) to Dec. 2025 (NT$24.5 Mil).

Greenyn Biotechnology Co Total Tax Payable Related Terms

Greenyn Biotechnology Co Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Greenyn Biotechnology Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenyn Biotechnology Co Total Tax Payable Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial 18.66 21.75 17.53 22.50 24.45

Greenyn Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.96 11.75 24.45 32.67 14.55
ROCO:6846
68GF Score
Greenyn Biotechnology Co Ltd ROCO:6846
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenyn Biotechnology Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of NT$14.6 Mil mean?
Greenyn Biotechnology Co (ROCO:6846) has a Total Tax Payable of NT$14.6 Mil as of Jun. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Greenyn Biotechnology Co and its competitors.
Is Greenyn Biotechnology Co's Total Tax Payable too high?
Greenyn Biotechnology Co's current Total Tax Payable is NT$14.6 Mil. Overall, Greenyn Biotechnology Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Greenyn Biotechnology Co's Total Tax Payable compare to VRTX and REGN?
Greenyn Biotechnology Co's Total Tax Payable of NT$14.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Greenyn Biotechnology Co and its competitors. Greenyn Biotechnology Co's current Total Tax Payable is NT$14.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenyn Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Greenyn Biotechnology Co (ROCO:6846) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$67.05, compared to a current price of NT$57.60 — trading 14.1% below its estimated fair value. The current Total Tax Payable is NT$14.6 Mil. Greenyn Biotechnology Co's overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Greenyn Biotechnology Co (ROCO:6846), the current Total Tax Payable is NT$14.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Greenyn Biotechnology Co (ROCO:6846) Overvalued in 2026?

Based on GuruFocus' analysis, Greenyn Biotechnology Co stock appears to be undervalued. The current stock price of NT$57.60 is trading 14.1% below its estimated GF Value™ of NT$67.05. GuruFocus considers Greenyn Biotechnology Co to be Modestly Undervalued.

Key valuation signals for ROCO:6846:

  • Total Tax Payable: NT$14.6 Mil
  • GF Value™: NT$67.05 vs. price of NT$57.60 (14.1% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Greenyn Biotechnology Co Business Description

Address No 43 Keya Road, 5th Floor, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd is engaged in the business of health food raw materials production and sales of raw materials and production and sales of formula preparation.
68GF Score

Get the complete analysis for ROCO:6846

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$57.60
Price
NT$67.05
GF Value